In a next step, we evaluated xenograft experiments with WNT2 overexpressing HCT116 colon cancer cells that we recently published on the role of WNT2 as a driver in colorectal cancer progression [24] to investigate the in vivo relevance of our findings. This evidence concerns the gene WNT2 and colonic neoplasm.